Last reviewed · How we verify
NCT03647397
PECO Air Purification in Hospital Rooms to Improve Health Outcomes for Pediatric Respiratory Distress
NA trial testing Photo Electrochemical Oxidation (PECO) for Air Purification in Asthma in 274 participants. Completed in 31 December 2018.
31 December 2018
Quick facts
| Lead sponsor | Molekule |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 274 |
| Start date | 8 August 2018 |
| Primary completion | 31 December 2018 |
| Estimated completion | 31 December 2018 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Photo Electrochemical Oxidation (PECO) for Air Purification
Conditions studied
- Asthma — all drugs for Asthma →
- Pneumonia — all drugs for Pneumonia →
- Respiratory Distress Syndrome — all drugs for Respiratory Distress Syndrome →
Sponsor
Molekule
Who can join
Adults 1 to 17, any sex, with Asthma or Pneumonia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will investigate the efficacy of a novel air purification technology, Photo Electrochemical Oxidation (PECO), has on pediatric patients hospitalized for respiratory distress. The study will take place at Mercyhealth Hospital - Rockton Avenue where all 23 pediatric rooms will be outfitted with portable PECO air purifying units. The main outcomes are the length of stay and progression to ICU, which will be compared with historical controls.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Impact of a New Portable Air Purification Technology Device in the Pediatric Hospital Setting - A Pre-post Assessment Study.
Rao NG, Kumar A, Colon C, Goswami DY. · · 2020 · cited 5× · PMID 32351820 · DOI 10.7759/cureus.7440
Verify or expand the search:
- PubMed search for NCT03647397
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Asthma
Currently open trials in the same condition.
- NCT07525375 — A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared t · Phase 2 · recruiting
- NCT07536256 — Community Connections Through Native Hawaiian Cultural Values to Strengthen Youth Resilience, Health, and Well-Being · NA · recruiting
- NCT07556159 — A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice · recruiting
- NCT07282886 — VENTURI (VENTilation Using Respiratory Imaging) · Phase 2 · recruiting
- NCT07433569 — A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Differ · Phase 1 · recruiting
Other Molekule trials
Trials by the same sponsor.
- NCT03627689 — Molekule for Allergic Rhinitis/Asthma · NA · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03647397 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Molekule
- Last refreshed: 17 May 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03647397.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing